Events

Congratulations to our company for executing the "SR-T100 Gel Clinical Trial for Cutaneous Squamous Cell Carcinoma In Situ (Actinic Keratosis) – Phase III Clinical Trial in Taiwan" new drug development project, which has been recognized as an outstanding case by the A+ Enterprise Innovation Program Office of the Ministry of Economic Affairs! An interview was conducted with the Management Science Society of the Republic of China on August 10, 2021.